AndroScience is a privately held San Diego, CA based drug discovery and clinical stage pharmaceutical company innovating proprietary small molecules to target disease dependent intracellular signaling events critical to the androgen receptor (AR) and Signal Transducer and Activation of Transcription (STAT) pathways. Our research and drug development strategy focuses on topical and oral treatment approaches in areas of significant medical and commercial importance, including several androgen related diseases and different forms of cancer. Each of ASC's therapeutic platforms demonstrate diverse medical applications, with lead compounds advanced in parallel for the treatment of pathologically related yet distinct clinical indications. Both of ASC’s two therapeutic platforms are first-in-class MOA small molecules which selectively and potently inhibit aberrant or excessive levels of transcription factors activation. An expanding pipeline of drug candidates is based on Androgen Receptor Degradation (ARD) Enhancers and selective STAT inhibitors. ARD Enhancers display remarkable treatment potential in: Acne (phase IIb), Alopecia (phase I/II), with preclinical stage proof of concept in Prostate Cancer, SBMA (Kennedy’s Disease), HBV induced HCC, Bladder Cancer, and Wound Healing. STAT inhibitor compounds possess efficacy against a wide range of aggressive solid and hematological cancers and are undergoing preclinical development and final lead identification.

ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Part of Alkermes Plc, Alkermes Controlled Therapeutics, Inc. is a company headquartered in the United States specializing in pharmaceutical preparations.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Jicui Health Industry Co., Ltd., established on 2014-04-10, The business scope includes health and nutrition food,medicine,Technology R&D of Cosmetics;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Wholesale of health food that helps relieve exercise fatigue;Import and export of goods and technology(Except for national restrictions and special approvals);Technical extension services;software development;market survey;Economic and Trade Consulting;grow grain,vegetable,fruit,the tea,spice crops,Chinese herbal medicine;sell grain,fresh vegetables,fresh fruits,unprocessed dried fruit,nut.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

Kallistem is a biotech company specialized in spermatogenesis. The company was founded in 2012 with the objective to anticipate and treat male infertility. It promotes a technology and expertise developed by Philippe Durand and Marie-Helene Perrard, two internationally renowned scientists in the field of the reproductive biology and more specially in in vitro spermatogenesis.Kallistem has developed, in collaboration with its partners, original and innovating technologies of germinal cell culture for male fertility preservation and the treatment of male infertility.

Nippon Zoki Pharmaceutical Co. Ltd. is a private company headquartered in Chuo-ku, Japan, that manufactures pharmaceutical products.

Manufactures pharmaceuticals and diagnostic substances

Repros Therapeutics Inc. ® was organized on August 20, 1987. We are a development stage biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

Operates a research institute for structural and solar research

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Morinaga Milk Industry Co., Ltd. engages in the production and distribution of dairy products. Its operations are carried out through the following segments: Food Products and Others. The Food Products segment engages in the production and sale of milk, dairy-based beverages, yogurt, desserts, condensed milk, powdered milk, butter, cheese, ice cream, non-dairy beverages (juice, tea, coffee), and clinical liquid diets. The Others segment provides the real estate leasing services. It also engages in the manufacture and sale of animal feeds; design and construction of plant equipment. The company was founded on September 1, 1917 and is headquartered in Tokyo, Japan.

The USC Incubator accelerates the development of USC’s top student and alumni entrepreneurs through experiential education, mentorship and community. The USC Incubator, supported by the Greif Center for Entrepreneurial Studies at USC’s Marshall School takes founders from feasibility and development work, on to customers, a tested business model, getting distribution, building a team, bootstrapping and investment preparation. They also provide access to other supporting resources, such as legal and financial assistance.